Taysha's R&D Chief Sold $1.2 Million in Stock After a 149% Run
Nagendran Sukumar executed the sale under a pre-established Rule 10b5-1 trading plan, retaining 936,410 shares worth $5.94 million.
Read the full articleYou might also wanna read
Insider Sell: Sukumar Nagendran Sells 200,000 Shares of Taysha Gene Therapies Inc (TSHA)
Related Stocks: TSHA
GuruFocus·6d ago
NXTS: Selling Stockholders to Offer 2.57 Million Shares
Related Stocks: NXTS
GuruFocus·3d ago
Insider Sell: Sumedh Thakar Sells Shares of Qualys Inc (QLYS)
Related Stocks: QLYS
GuruFocus·22h ago
Shuttle Pharma stock jumps 41% as turnover hits 82 times its share base
NEW YORK, July 14, 2026, 16:13 EDT Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) shares closed 40.5% higher at $4.16 on Tuesday after
ts2.tech·2d ago
WBD CEO David Zaslav Moves to Sell Another $59.5 Million in Company Shares
Discovery CEO David Zaslav has filed to sell about 2.18 million shares of the company’s stock valued at roughly $59.47 million, according to
olorisupergal.com·3d ago
SBI sells 1.42% stake for ₹1,655 cr in SBI Funds Management ahead of arm's IPO
SBI sold the shares to investors including 360 ONE funds, Tata AIG General Insurance Company, Go Digit General Insurance, Bennett Coleman, A
thehindubusinessline.com·6d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.